Target intelligence / Profile preview

Mitochondrial membrane transporter protein

Molecular classification
Transporter, Solute carrier family member (e.g., SLC25), Membrane protein
01

Overview

Mitochondrial membrane transporter proteins are a group of integral membrane proteins primarily located in the inner mitochondrial membrane. They are responsible for the regulated movement of ions, metabolites, and cofactors between the mitochondrial matrix and the cytosol, critical for cellular energy metabolism, metabolite exchange, and apoptosis regulation. Major subgroups include the solute carrier family (notably SLC25), adenine nucleotide translocators, and mitochondrial pyruvate carriers. Dysfunction or mutation in these transporters is implicated in a wide range of metabolic, neurodegenerative, and other diseases. Due to their central role in cell metabolism, these transporters are considered significant drug targets for a variety of disorders, although the generic term "mitochondrial membrane transporter protein" is insufficient to specify a single molecular target[2][3][4]. If you are interested in a particular member of this transporter class, such as "Adenine nucleotide translocator (ANT)" or "Mitochondrial pyruvate carrier," please specify for a more precise structured mapping.

Other names
Mitochondrial carrier proteinMitochondrial transport proteinSLC25 family transporterMitochondrial inner membrane transporter
02

Mechanism of action

Inhibition or modulation of substrate transport across the inner mitochondrial membrane (e.g., blocking ATP/ADP exchange, pyruvate transport)

03

Biological functions

Transport of small molecules (e.g., ADP/ATP, pyruvate, amino acids)Maintenance of mitochondrial membrane potentialSupport of oxidative phosphorylation and energy productionCell death/apoptosis regulation (through proteins like the voltage-dependent anion channel)
04

Disease associations

Neurodegenerative diseasesInherited metabolic disorders (due to transporter mutations)CancerMitochondrial disorders
05

Safety considerations

Risk of mitochondrial toxicity (inhibition may cause ATP depletion)Off-target effects impacting cellular energy homeostasisPotential for causing or worsening mitochondrial dysfunction
06

Interacting drugs

Bongkrekic acid (inhibitor of the adenine nucleotide translocator/ANT)

2 more in the full profile.

07

Biomarkers

Altered expression or function of specific transporters (e.g., SLC25A family genes) in mitochondrial diseases, some cancers, and metabolic disorders

Beyond the preview

Go deeper on Mitochondrial membrane transporter protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial membrane transporter protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call